A PILOT TRIAL OF ADRIAMYCIN, PEMBROLIZUMAB, VINBLASTINE AND DACARBAZINE (APVD) FOR PATIENTS WITH UNTREATED CLASSICAL HODGKIN LYMPHOMA. (12th June 2019) - Lynch, R.C.; Smith, S.D.; Shadman, M.; Ujjani, C.S.; Kurtz, D.M.; Coye, H.; Till, B.G.; Warren, E.H.; Shustov, A.R.; Maloney, D.G.; Tseng, Y.D.; Gopal, A.K.